These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2422465)

  • 1. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
    Unger T; Moursi M; Ganten D; Hermann K; Lang RE
    J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
    Unger T; Fleck T; Ganten D; Lang RE; Rettig F
    Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme inhibitors and brain angiotensin.
    Phillips MI; Kimura B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
    Unger T; Ganten D; Lang RE
    Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
    Rowland NE; Fregly MJ
    Behav Neurosci; 1988 Dec; 102(6):953-60. PubMed ID: 2850816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
    Campbell DJ; Duncan AM; Kladis A; Harrap SB
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):426-36. PubMed ID: 8583785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
    Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Schölkens BA; Becker RH; Kaiser J
    Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.
    Richer C; Doussau MP; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):12D-17D. PubMed ID: 3034019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
    Campbell DJ; Lawrence AC; Towrie A; Kladis A; Valentijn AJ
    Hypertension; 1991 Dec; 18(6):763-73. PubMed ID: 1660448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting enzyme inhibitor-induced changes of plasma angiotensinogen concentration in the rat.
    Radziwill R; Stuzmann M; Hilgenfeldt U; Hackenthal E
    Eur J Pharmacol; 1986 Mar; 122(1):59-64. PubMed ID: 3007179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
    J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.